Intracytoplasmic sperm injection with polyvinylpyrrolidone: A potential risk [6]

Fertility and Sterility

Volumn 76, Issue 2, 2001, Pages 419-420

  Jean, Miguel ^a,c   Mirallié, Sophie ^a   Boudineau, Marc ^b   Tatin, Christine ^a   Barrière, Paul ^a  

^a Service de Biologie et Médecine du Développement et de la Reproduction   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Hopital Mere Enfant CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; LYSOSOME ENZYME; PLASMA SUBSTITUTE; POVIDONE;

BEVERAGE; CELL STRUCTURE; CHROMOSOME ABERRATION; CONGENITAL MALFORMATION; COSMETIC INDUSTRY; DRUG ACCUMULATION; DRUG EFFECT; DRUG METABOLISM; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LETTER; MALE INFERTILITY; OOCYTE; PRIORITY JOURNAL; RISK; SKIN DEFECT; SPERMATOZOON MATURATION; STORAGE DISEASE; TOXICITY;

EID: 0034901329     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)01874-X     Document Type: Article

References (8)

1. Intracytoplasmic sperm injection without polyvinylpyrrolidone: An essential precaution?
2. Sex chromosomal abnormalities and intracytoplasmic injection
3. Development of a successful ICSI programme without the use of PVP
4. "Mucoid dissolution" of bones and multiple pathologic fractures in a patient with past history of intravenous administration of polyvinylpyrrolidone (PVP). A case report
5. Detrimental effects of polyvinylpyrrolidone on the ultrastructure of spermatozoa (Notulae seminologicae 13)
6. High fertilization rate with intracytoplasmic sperm injection in mosaic Klinefelter's syndrome
7. Development of a successful ICSI programme without the use of PVP
8. A modified method of intracytoplasmic sperm injection without the use of polyvinylpyrrolidone